A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model-Reference-Cited by-同舟云学术

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model

Published:2021-09-13 Issue: Volume: Page:
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Peter Antonia Sophia¹,Roth Edith²,Schulz Sebastian R.²,Fraedrich Kirsten¹,Steinmetz Tobit²,Damm Dominik¹,Hauke Manuela²,Richel Elie¹,Mueller‐Schmucker Sandra¹,Habenicht Katharina³,Eberlein Valentina⁴,Issmail Leila⁴,Uhlig Nadja⁴,Dolles Simon⁵,Grüner Eva¹,Peterhoff David⁶⁷,Ciesek Sandra⁸⁹¹⁰,Hoffmann Markus¹¹¹²,Pöhlmann Stefan¹¹¹²,McKay Paul F.¹³,Shattock Robin J.¹³,Wölfel Roman¹⁴¹⁵,Socher Eileen¹¹⁶¹⁷,Wagner Ralf⁶,Eichler Jutta⁵,Sticht Heinrich¹⁶,Schuh Wolfgang²,Neipel Frank¹,Ensser Armin¹,Mielenz Dirk²,Tenbusch Matthias¹,Winkler Thomas H.³,Grunwald Thomas⁴,Überla Klaus¹,Jäck Hans‐Martin²^ORCID

Affiliation:

1. Institute of Clinical and Molecular Virology University Hospital Erlangen Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

2. Division of Molecular Immunology Internal Medicine III Nikolaus‐Fiebiger‐Center of Molecular Medicine Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

3. Division of Genetics Department Biology Nikolaus‐Fiebiger‐Center of Molecular Medicine Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

4. Department of Immunology Fraunhofer Institute for Cell Therapy and Immunology IZI Leipzig Germany

5. Department of Chemistry & Pharmacy Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

6. Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology) University of Regensburg Regensburg Germany

7. Institute of Clinical Microbiology and Hygiene University Hospital Regensburg Regensburg Germany

8. Institute of Medical Virology University Hospital Frankfurt Goethe University Frankfurt Frankfurt Germany

9. German Centre for Infection Research External Partner Site Frankfurt Germany

10. Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) Branch Translational Medicine and Pharmacology Frankfurt Germany

11. Infection Biology Unit German Primate Center Göttingen Germany

12. Faculty of Biology and Psychology Georg‐August‐University Göttingen Göttingen Germany

13. Department of Infectious Diseases Imperial College London London UK

14. Bundeswehr Institute of Microbiology Munich Germany

15. German Center for Infection Research Partner Site Munich Munich Germany

16. Division of Bioinformatics Institute of Biochemistry Emil‐Fischer Center Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

17. Institute of Anatomy, Functional and Clinical Anatomy Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202149374

Reference65 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. [Internet] Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.COVID‐19 Dashboard.2021[cited 2021 April 09] Available fromhttps://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.

3. COVID-19 vaccines: where we stand and challenges ahead

4. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

5. Estimating real‐world COVID‐19 vaccine effectiveness in Israel using aggregated counts;Aran D.;medRxiv,2021

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity;ChemMedChem;2024-08-06

2. Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model;Journal of Virology;2024-07-23

3. Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2;Communications Biology;2024-07-16

4. Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand;Pharmaceutics;2023-12-23

5. B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity;Cellular & Molecular Immunology;2023-11-10